Graphic: Viktoria Nikolova for Endpoints News

In clash over sci­ence and na­tion­al se­cu­ri­ty, Chi­nese ri­val to Il­lu­mi­na strug­gles with US ex­pan­sion

The pitch from Chi­na’s MGI Tech to US labs seems ap­peal­ing: Its DNA se­quenc­ing ma­chines can de­code a genome for around $100, an im­por­tant bench­mark in the world of high-cost re­search.

But more than a year af­ter its US launch, MGI has found a chilly re­cep­tion in a mar­ket that con­tin­ues to be dom­i­nat­ed by Il­lu­mi­na, End­points News learned through a re­view of ear­ly sales da­ta and con­ver­sa­tions with in­dus­try ex­perts.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.